Crossover Trial of AD109 in Obstructive Sleep Apnea
Condition: Obstructive Sleep Apnea Interventions: Drug: AD109; Drug: Atomoxetine; Drug: R-oxybutynin; Drug: Placebo Sponsor: Apnimed Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Obstructive Sleep Apnea | Oxybutynin | Research | Sleep Apnea | Sleep Disorders | Sleep Medicine | Strattera